API16 products
Antitumor
Small-molecule kinase inhibitors including Gefitinib, Erlotinib, Sorafenib, Imatinib and Ibrutinib.
View productsWe develop and manufacture active pharmaceutical ingredients and advanced intermediates at GMP-compliant facilities in China — and support customers worldwide with custom synthesis, technology transfer and Mainland China registration.
Product catalog
Two product families across our core therapeutic areas — every product listed with its CAS number, searchable in one catalog.
API16 products
Small-molecule kinase inhibitors including Gefitinib, Erlotinib, Sorafenib, Imatinib and Ibrutinib.
View productsAPI8 products
Sartans, statins and anticoagulants including Losartan, Valsartan, Apixaban and Rivaroxaban.
View productsIntermediate31 products
Quinazoline, pyrrole and indole building blocks for Gefitinib, Erlotinib and Sunitinib synthesis routes.
View productsQuality
Each batch we release passes staged quality assurance and quality control, backed by continuous investment in the analytical capability of our QC laboratory.
Manufacturing
Production facilities in Anhui and Shanxi provinces, designed in strict compliance with GMP standards, cover reaction volumes from 500 L to 5,000 L — from first commercial batches to established volume supply.
Services
Technical and regulatory services that carry a molecule from our facility into your market.
Complete API technology packages, adjusted to the requirements of your target market.
Synthesis of new compounds in support of your development pipeline.
Sourcing and matching of pharmaceutical production equipment.
Audit and product registration support in Mainland China.
Start an inquiry
Send us the product name or CAS number, the quantity you need, and your destination market — our team will respond with specifications, availability and lead times.